OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma

Clinical trial NCT03429816 · COMPLETED

Trial details

NCT number: NCT03429816
Sponsor: University Hospital Heidelberg
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Gastric Neoplasm Gastroesophageal Junction Adenocarcinoma Esophageal Adenocarcinoma Gastric Adenocarcinoma Esophageal Neoplasms

Start date: 2018-04-15
Primary completion: 2021-11-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.